Profil
Howard has been a Board Member at Cure Kids Ventures since 2008.
Howard’s breadth of experience spans multiple industries including venture capital, agritech, foodtech, and biotech.
His career is hallmarked by fund raising, technology commercialisation, early stage company development and sales and marketing.
Howard had previously co-founded Tercica, an Auckland based biotech company which he relocated to the US and later went on to float on the NASDAQ.
After returning to New Zealand, Howard took a position as Executive Director of BioPacific Ventures, a $100 million Direct Capital life science fund.
Howard is currently CEO of Pictor Limited, a CKV investee company, commercialising a diagnostic testing system.
Howard graduated from Massey University with a Bachelor of Food Technology and maintains an avid interest in improving the profitability of the life science sector.
Postes actifs de Howard Moore
| Sociétés | Poste | Début |
|---|---|---|
Pictor Ltd.
 Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Directeur des opérations | 10/08/2020 |
NZeno Ltd.
 NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Président | 01/01/2020 |
Cure Kids Ventures Ltd.
 Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | 01/01/2008 |
Anciens postes connus de Howard Moore
| Sociétés | Poste | Fin |
|---|---|---|
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Fondateur | 01/03/2004 |
Formation de Howard Moore
| Massey University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Cure Kids Ventures Ltd.
Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Finance |
Pictor Ltd.
Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Health Technology |
NZeno Ltd.
NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Health Services |